Phosphoinositide 3-Kinase Inhibitors Combined with Imatinib in Patient-Derived Xenograft Models of Gastrointestinal Stromal Tumors: Rationale and EfficacyThomas Van Looy, Patrick Schöffski, Paul W. Manley et al.|Clinical Cancer Research|2014Cited by 50
Supplemental Figures Legend from Phosphoinositide 3-Kinase Inhibitors Combined with Imatinib in Patient-Derived Xenograft Models of Gastrointestinal Stromal Tumors: Rationale and EfficacyThomas Van Looy, Patrick Schöffski, Paul W. Manley et al.|Unknown|2023Cited by 0
Table S2 from Phosphoinositide 3-Kinase Inhibitors Combined with Imatinib in Patient-Derived Xenograft Models of Gastrointestinal Stromal Tumors: Rationale and EfficacyThomas Van Looy, Patrick Schöffski, Agnieszka Woźniak et al.|Unknown|2023Cited by 0
Table S2 from Phosphoinositide 3-Kinase Inhibitors Combined with Imatinib in Patient-Derived Xenograft Models of Gastrointestinal Stromal Tumors: Rationale and EfficacyThomas Van Looy, Patrick Schöffski, Agnieszka Woźniak et al.|Unknown|2023Cited by 0